Table 2. Subgroup analyses of prevalence of psychological distress in patients with breast cancer.
Subgroup | No of included studies | Prevalence (%) | 95%CI | I2 (%) | P value |
Tool | |||||
DT | 10 | 63 | 0.50 to 0.74 | 97 | <0.01 |
HADS | 8 | 41 | 0.31 to 0.52 | 96 | <0.01 |
DT+PL | 3 | 27 | 0.17 to 0.37 | 97 | <0.01 |
DASS | 3 | 60 | 0.34 to 0.84 | 98 | <0.01 |
Country | |||||
Developed country | 15 | 47 | 0.37 to 0.58 | 98 | <0.01 |
Developing country | 11 | 53 | 0.40 to 0.66 | 99 | <0.01 |
Sample | |||||
≥400 | 11 | 49 | 0.38 to 0.60 | 99 | <0.01 |
<400 | 16 | 51 | 0.39 to 0.62 | 97 | <0.01 |
Period | |||||
Before COVID-19 | 16 | 48 | 0.38 to 0.58 | 98 | <0.01 |
After COVID-19 | 11 | 53 | 0.38 to 0.67 | 99 | <0.01 |
DTDistress ThermometerHADSHospital Anxiety and Depression ScalePLproblem list